1. Mass spectral analysis of mouse serum proteome to predict tumor clearance. (4th November 2015) Authors: Woller, Norman; Roder, Heinrich; Knocke, Sarah; Meyer, Krista; Grigorieva, Julia; Asmellash, Senait; Sayers, Kevin; Maher, Caroline Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Mass spectral analysis of mouse serum proteome to predict tumor clearance. Issue 2 (December 2015) Authors: Woller, Norman; Roder, Heinrich; Knocke, Sarah; Meyer, Krista; Grigorieva, Julia; Asmellash, Senait; Sayers, Kevin; Maher, Caroline Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Pre-treatment patient selection for nivolumab benefit based on serum mass spectra. (4th November 2015) Authors: Weber, Jeffrey; Martinez, Alberto J; Roder, Heinrich; Roder, Joanna; Meyer, Krista; Asmellash, Senait; Grigorieva, Julia; Tsypin, Maxim; Oliveira, Carlos; Steingrimsson, Arni; Sayers, Kevin; Bacchiocchi, Antonella; Sznol, Mario; Halaban, Ruth; Kluger, Harriet Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Pre-treatment patient selection for nivolumab benefit based on serum mass spectra. Issue 2 (December 2015) Authors: Weber, Jeffrey; Martinez, Alberto; Roder, Heinrich; Roder, Joanna; Meyer, Krista; Asmellash, Senait; Grigorieva, Julia; Tsypin, Maxim; Oliveira, Carlos; Steingrimsson, Arni; Sayers, Kevin; Bacchiocchi, Antonella; Sznol, Mario; Halaban, Ruth; Kluger, Harriet Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗